Tobacco cessation in 2013: what every clinician should know

Carrie Harrill-Smith; Carol Ripley-Moffitt; Adam O Goldstein

Tobacco cessation in 2013: what every clinician should know

N C Med J. 2013 Sep-Oct;74(5):401-5.

Authors

Carrie Harrill-Smith¹, Carol Ripley-Moffitt, Adam O Goldstein

Affiliation

¹ Corresponding author: Dr. Adam O. Goldstein, Department of Family Medicine, University of North Carolina School of Medicine, Campus Box 7595, Manning Dr., Chapel Hill, NC 27599-7595, USA. aog@med.unc.edu.

PMID: 24165767

Abstract

Given the many deaths caused by smoking, clinicians should offer evidence-based treatment to every patient who uses tobacco. This commentary discusses health system changes that promote treatment for tobacco use, new protocols for tobacco cessation therapies, and emerging tobacco products that are being marketed as harm-reduction tools.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Cholinergic Agents / therapeutic use
Clinical Protocols
Hotlines
Humans
North Carolina
Professional Role
Smoking Cessation / methods
Tobacco Use Cessation / methods*
Tobacco Use Disorder / diagnosis
Tobacco Use Disorder / drug therapy*
Tobacco Use Disorder / epidemiology

Substances

Cholinergic Agents